摘要
本文介绍了目前正处于临床试验的人类免疫缺陷病毒 1(HIV 1)整合酶抑制剂S 136 0和L 870 810 ;另外 ,主要叙述了近年来发展比较迅速的三大类HIV 1整合酶抑制剂 ,即一般含芳环化合物、寡聚核苷酸和寡聚肽的研究进展。
出处
《国外医学（药学分册）》
2004年第2期65-69,共5页
Foreign Medical Sciences(Section of Pharmarcy)
参考文献19
-
1Abdel-Rahman HM, Al-Karamany GS, El-Koussi NA,et al. HIV protease inhibitors: peptidomimetic drugs and future perspectives[J]. Curr Med Chem, 2002, 9(21):1905- 1922.
-
2DebyserZ, Cherepanov P, Van Maele B, el. Insearch of authentic inhibitors of HIV-1 integration [J]. Antivir Chem Chemother, 2002, 13(1):1 - 15.
-
3Zouhiri F, Mouscadet JF, Medkouar K, et al. Structureactivity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1in cell culture[J]. J Med Chem, 2000, 43(8): 1533 -1540.
-
4Dayam R, Neamati N. Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update [J]. Curr Pharm Des,2003, 9(22): 1789 - 1802.
-
5Billich A. S-1360 Shionogi-GlaxoSmithKline[J]. Curr Opin Investig Drugs , 2003, 4(2):206-209.
-
6Boyle BA. Recent developments in HIV research[J]. AIDS Read, 2002,12(9):390-394.
-
7Marchand C, Zhang X, Pais GC, et al. Structural determinants for HIV-1 integrase inhibition by β-diketo acids[J]. J Biol Chem, 2002, 277(15): 12596- 12603.
-
8Wai JS, Egbertson MS, Payne LS, et al. 4-Aryl - 2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells[J]. J Med Chem, 2000, 43(26):4923 - 4926.
-
9Maurin C, Bailly F, Cotelle P. Stucture-activity relationships of HIV-1 integrase inhibitors - enzyme-ligand interactions[J]. Curr Med Chem, 2003, 10(18):1795- 1810.
-
10Hwang DJ, Kim SN, Choi JH, et al. Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors[J]. Bioorg Med Chem, 2001, 9(6), 1429-1437.
同被引文献33
-
1周婷,谢蓝.HIV非核苷类逆转录酶抑制剂研究进展[J].药学学报,2004,38(8):666-672. 被引量：17
-
2裴明军,桂向东,宋礼华.Cyanovirin-N:一种新型灭活HIV-1蛋白的研究进展[J].国外医学（预防．诊断．治疗用生物制品分册）,2004,27(5):220-224. 被引量：4
-
3丁玉兰,赵树进,蒋琳兰,陈晓晖.HIV疫苗的研究进展[J].广东医学,2004,25(11):1342-1344. 被引量：1
-
4姚勤伟,黄春,吴昊.HIV-1逆转录酶耐核苷类药物突变新进展[J].国外医学（流行病学．传染病学分册）,2004,31(6):343-345. 被引量：2
-
5梁峰,李科,李国秀.HIV-1逆转录酶抑制剂的研究新进展[J].解放军药学学报,2004,20(6):450-453. 被引量：2
-
6Hazuda D, Felock PJ, Hasings JC, et al. Discovery and analysis of inhibitor of the human immunodeficlency integrase[ J]. Drug Des Discov,1997,15(1):17-24
-
7Mark R Fesen, Kurt W Kohn, et al. Inhibitors of human immunodeficiency virus integrase [ J ]. Proc. Natl. Acad. Sci.USA, 1993,90:2 399-2 403
-
8Farnet CM,Wang B,Lipford JR,et al. Differential inhibition of HIV- 1 preintegration complexes and purified integrase protein[J]. Proc Nan Acad Sei USA,1996,93(18) :9 743
-
9Farnet CM, Wang B, Hansen M, et al. Human immunodeficiency virus type 1 cDNA integration:new aromatic hydroxylated inhibitiors and studies of the inhibitiion mechanism[ J ]. Antimicrob Agents And Chemotherapy, 1998,42 ( 9 ) :2 245
-
10Markgren PO. Relationships between structure and interaction kinetics for HIV - 1 protease inhibitors [ J ]. J Med Chem,2002,45 (25) :5 430-5 439
-
1张季平.喹诺酮类药物研究进展及其临床应用[J].新药与临床,1994,13(2):93-95. 被引量：41
-
2毛东阳,毛志道.氟喹诺酮类药物的相互作用及不良反应[J].中华临床医药杂志（北京）,2004,5(11):111-112.
-
3新型抗艾滋病毒药物S—1360问世[J].传染病网络动态,2002(8):30-30.
-
4蔡宇晹,吴梧桐.反义寡聚核苷酸及其在医药领域的进展[J].中国药科大学学报,1993,24(4):253-256.
-
5马帅,高文磊,赵俊,曹胜华.人类免疫缺陷病毒-1整合酶抑制剂的研究进展[J].中国药学杂志,2014,49(21):1877-1881. 被引量：5
-
6钱江潮,魏东芝.反义核酸的修饰及其类似物的研究进展[J].国外医学（药学分册）,1997,24(4):223-229. 被引量：5
-
7郑谷,陈金东.人工合成寡聚核苷酸的简便纯化法[J].南京铁道医学院学报,1994,13(1):61-62. 被引量：1
-
8王志军,姜延程.DNA疫苗佐剂Poly(LacNAc/Gln-co-Glu)的合成[J].上海化工,2000,25(13):15-16.
-
9刘照强,于钊,展鹏,刘新泳.HIV-1非核苷类逆转录酶抑制剂研究新进展(2014～2015年)[J].中国药物化学杂志,2015,25(6):470-484. 被引量：1
-
10汤小明.合理使用第四代喹诺酮类药物[J].中外医学研究,2010,8(4):63-64. 被引量：1
